Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tibet Changdu Kangyuan Pharmaceutical is a specialized pharmaceutical company based in the Tibet Autonomous Region of China. It operates as a wholly-owned subsidiary of Jiangsu Kanion Pharmaceutical, a prominent leader in the modernization of Traditional Chinese Medicine (TCM). The company focuses on the production, processing, and distribution of pharmaceutical products that utilize the unique medicinal flora found on the Tibetan plateau. Its therapeutic portfolio primarily addresses respiratory infections, gynecological disorders, and cardiovascular health through high-quality botanical extracts and herbal formulations. The facility operates under strict Good Manufacturing Practice (GMP) standards to ensure the safety and efficacy of its traditional-based therapies. As a strategic regional hub, it plays a vital role in the parent company's supply chain and market expansion within western China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tibet Changdu Kangyuan Pharmaceutical.